Chloroquine and bafilomycin A mimic lysosomal storage disorders and impair mTORC1 signaling.

Autophagy is dependent upon lysosomes, which fuse with the autophagosome to complete the autophagic process and whose acidic interior permits the activity of their intraluminal degradative enzymes. Chloroquine (CQ) and bafilomycin A1 (BafA) each cause alkalinisation of the lumen and thus impair lysosomal function, although by distinct mechanisms. CQ diffuses into lysosomes and undergoes protonation, while BafA inhibits the ability of the vacuolar type H+-ATPase (v-ATPase) to transfer protons into the lysosome. In this study, we examine the impact of CQ and BafA on the activity of mammalian target of rapamycin complex 1 (mTORC1), inhibition of which is an early step in promoting autophagy. We find each compound inhibits mTORC1 signaling, without affecting levels of protein components of the mTORC1 signaling pathway. Furthermore, these effects are not related to these agents' capacity to inhibit autophagy or the reduction of amino acid supply from lysosomal proteolysis. Instead, our data indicate that the reduction in mTORC1 signaling appears to be due to the accumulation of lysosomal storage material. However, there are differences in responses to these agents, for instance, in their abilities to upregulate direct targets of transcription factor EB (TFEB), a substrate of mTORC1 that drives transcription of many lysosomal and autophagy-related genes. Nonetheless, our data imply that widely used agents that alkalinise intralysosomal pH are mimetics of acute lysosomal storage disorders and emphasise the importance of considering the result of CQ and BafA on mTORC1 signaling when interpreting the effects of these agents on cellular physiology.